BIO-key International (BKYI) Expected to Release Quarterly Earnings on Friday

BIO-key International (NASDAQ:BKYI) is projected to announce its Q3 2026 results on Friday, November 13th. Analysts expect BIO-key International to post earnings of ($0.35) per share and revenue of $2.40 million for the quarter. Interested persons may review the information on the company’s upcoming Q3 2026 earnings results page for the latest details on the call scheduled for Friday, November 13, 2026 at 10:00 AM ET.

BIO-key International (NASDAQ:BKYI) last issued its quarterly earnings data on Thursday, August 13th. The technology company reported ($0.56) EPS for the quarter, topping the consensus estimate of ($0.82) by $0.26. The company had revenue of $1.92 million during the quarter, compared to analyst estimates of $1.80 million. BIO-key International had a negative return on equity of 67.31% and a negative net margin of 50.01%. On average, analysts expect BIO-key International to post ($1.62) EPS for the current fiscal year and $0.22 EPS for the next fiscal year.

BIO-key International Trading Down 1.3%

BKYI stock opened at $2.36 on Wednesday. BIO-key International has a 1-year low of $1.55 and a 1-year high of $11.10. The stock has a market cap of $4.80 million, a price-to-earnings ratio of -0.57 and a beta of 0.52. The company’s 50 day moving average is $2.49 and its 200 day moving average is $4.44.

Analysts Set New Price Targets

A number of equities analysts have recently commented on BKYI shares. Zacks Research raised shares of BIO-key International to a “hold” rating in a report on Thursday, August 6th. Wall Street Zen upgraded shares of BIO-key International to a “hold” rating in a research report on Saturday, October 24th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of BIO-key International in a report on Thursday, October 15th. One investment analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of “Reduce”.

BIO-key International Company Profile

BIO-key International, Inc. (NASDAQ: BKYI) develops biometric authentication and identity and access management solutions. The company helps organizations secure access to applications, networks, devices and data through fingerprint recognition and other authentication methods designed to reduce reliance on passwords. Its product portfolio includes PortalGuard, an identity and access management platform that supports single sign-on, multifactor authentication, self-service password management and access control.